Abstract
Hyperthermic intraperitoneal chemotherapy (HIPEC) is a technique, which delivers heated chemotherapeutic agents into the peritoneal cavity. It has been shown to improve prognosis and survival rate in patients of colorectal, ovarian and gastric cancers with peritoneal metastasis. A 57-year-old man diagnosed with primary colorectal carcinoma and pseudomyxoma peritonei was posted for HIPEC surgery. General anaesthesia with epidural analgesia (pain management) and invasive lines (arterial, central) for managing fluid shifts were used. Stroke volume variation was measured throughout the 19-hour procedure for goal directed fluid therapy (GDT) and to maintain urine output. Temperature monitoring with deliberate cooling measures were used during the period of HIPEC along with serial arterial blood gas analysis (ABG).
| Original language | English |
|---|---|
| Pages (from-to) | 118-121 |
| Number of pages | 4 |
| Journal | Sri Lankan Journal of Anaesthesiology |
| Volume | 29 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Anesthesiology and Pain Medicine
Fingerprint
Dive into the research topics of 'What’s hitech about crs-hipec?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver